Similar Articles
Biperiden dependence and differential diagnosis with neuroleptic malignant syndrome: A case report
Mehmet Hamdi Örüm, Mahmut Zabit Kara, Gamze Örüm, Oğuzhan Bekir Eğilmez
DOI: 10.5606/fng.btd.2018.033
Relationship between treatment modalities, glycemic control, and diabetes complications with risk of depression and anxiety in type 2 diabetes mellitus patients
Serkan Günalay, Emin Taşkıran, Bilgin Demir, Semiha Erdem, Haluk Mergen, Harun Akar
DOI: 10.5606/fng.btd.2016.004
Investigation of attachment dimensions in panic disorder and major depression
Serdal Özdemir, Fatma Özdemir, Süheyla Ünal
DOI: 10.5606/fng.btd.2016.008
The treatment process of a patient with postpartum depression who conceived with in vitro fertilization technique: A case report
Mehmet Hamdi Örüm, Aysun Kalenderoğlu
DOI: 10.5606/fng.btd.2017.025
Evaluation of the psychiatry consultations of inpatients in Palliative Care Unit of Adiyaman Training and Research Hospital: 2018 data
Mehmet Hamdi Örüm, Mahmut Zabit Kara, Gamze Örüm, Oğuzhan Bekir Eğilmez
DOI: 10.5606/fng.btd.2019.014
Placebo and nocebo effects: An introduction to the terms and their presence in oncology
Erald Bakiu, Tolunay Akbaş, Funda İfakat Tengiz
DOI: 10.5606/fng.btd.2020.25015
Noncoding RNA-targeted treatment for schizophrenia: CRISPR/CAS9
Çağatay Özulu, Oytun Erbaş
DOI: 10.5606/fng.btd.2021.25067
Comparison of anxiety and depression scores between patients with and without ST-segment elevation acute coronary syndrome
Mert Palabıyık, Ümit Yaşar Sinan, Özge Çetinarslan, Veysel Oktay, Alev Arat Özkan
DOI: 10.5606/fng.btd.2021.25072
Anti-neuronal antibodies in schizophrenia spectrum disorders
Ayşe Safiye Genç, Oytun Erbaş
DOI: 10.5606/fng.btd.2022.08652
Dopamine dynamics in autism: Unraveling the neurochemical puzzle
Ebru Bardaş Özkan, Mehtap Odabaşı
DOI: 10.5606/fng.btd.2023.130